John Sperzel

2020

In 2020, John Sperzel earned a total compensation of $3.5M as President and Chief Executive Officer at T2 Biosystems.

Compensation breakdown

Non-Equity Incentive Plan$393,750
Option Awards$2,571,384
Salary$490,705
Other$3,000
Total$3,458,839

Sperzel received $2.6M in option awards, accounting for 74% of the total pay in 2020.

Sperzel also received $393.8K in non-equity incentive plan, $490.7K in salary and $3K in other compensation.

Rankings

In 2020, John Sperzel's compensation ranked 3,353rd out of 13,090 executives tracked by ExecPay. In other words, Sperzel earned more than 74.4% of executives.

ClassificationRankingPercentile
All
3,353
out of 13,090
74th
Division
Manufacturing
1,303
out of 5,618
77th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
158
out of 799
80th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
86
out of 495
83rd
Industry
Surgical and Medical Instruments and Apparatus
59
out of 313
81st
Source: SEC filing on May 14, 2021.

Sperzel's colleagues

We found four more compensation records of executives who worked with John Sperzel at T2 Biosystems in 2020.

2020

John McDonough

T2 Biosystems

Chief Executive Officer

2020

Anthony Pare

T2 Biosystems

Chief Commercial Officer

2020

Alec Barclay

T2 Biosystems

Chief Operations Officer

2020

Michael Gibbs

T2 Biosystems

General Counsel

News

In-depth

You may also like